Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
N.MMED.WR
Primary Symbol:
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED.WA
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(10)
•••
Bigmoneytalks
X
View Profile
View Bullboard History
Comment by
Bigmoneytalks
on Apr 03, 2024 6:50pm
RE:3 Month Predictions
Hell of a day! Big volume as well
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 7:07am
New Press Release - MindMed to Present at Upcoming April Medical Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present posters describing the impact that COVID has had on...
read article.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 01, 2024 5:02pm
New Press Release - MindMed Announces Voluntary Delisting from Cboe Canada
All Common shares will remain listed on Nasdaq Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it has elected to...
read article.
(10)
•••
Bigmoneytalks
X
View Profile
View Bullboard History
Post by
Bigmoneytalks
on Mar 27, 2024 4:32pm
3 Month Predictions
Not a lot of chatter on the forum... It has been a nice jump in SP the last 3 weeks and holding at current prices. What are some predictions on SP the next 3 months?
(15)
•••
mikesright
X
View Profile
View Bullboard History
Post by
mikesright
on Mar 21, 2024 3:36pm
Musk endorses Ketamine use
Mmed is the cream de La crme of psychedelics. Not selling until at least $20 But I think I.m going to be taking a full position in Phrm which is nearing word from fda on Ketamine production
...more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 08, 2024 1:45pm
MindMeds Systematic Biotech Approach With New FDA Therapy De
JUST IN: $MNMD MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds | BenzingaShortly following the news on FDA@s "
...more
(36)
•••
BryceCanada
X
View Profile
View Bullboard History
Post by
BryceCanada
on Mar 07, 2024 6:57pm
Thoughts on CYBN vs MNMD?
https://youtu.be/uW0vvAkSo18?si=efXVdd8f0bVqOrFV
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 07, 2024 10:45am
What's Going On With MindMed Stock Thursday? | Benzinga
Breaking News: $MNMD What's Going On With MindMed Stock Thursday? | BenzingaMind Medicine Inc (NASDAQ:MNMD) shares are trading higher Thursday after the company received FDA breakthrough therapy
...more
(2)
•••
brownbear
X
View Profile
View Bullboard History
Post by
brownbear
on Aug 14, 2023 7:42am
MindMed Secures $50.0 Million Credit Facility with K2 Health
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health
...more
(0)
•••
StockJunkie4994
X
View Profile
View Bullboard History
Post by
StockJunkie4994
on Jun 28, 2023 1:10pm
Breaking
https://thedalesreport.com/psychedelics/maps-ppc-coo-provides-roadmap-for-psychedelic-therapy-pathway-into-the-mainstream/
(2)
•••
brownbear
X
View Profile
View Bullboard History
Post by
brownbear
on Jun 10, 2023 11:39am
Quiet Board
This board has been quiet for sme time, anyone have any thoughts on were this is all going. Thanks
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 03, 2022 7:30am
New Press Release - MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update
NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on Thursday...
read article.
(100)
•••
GajjarDr
X
View Profile
View Bullboard History
Post by
GajjarDr
on Oct 10, 2022 6:58pm
RE:RE Quiet Over Here. New Member needs Advice...
I am holder too Silo Wellness. Not to be confused with Silo Pharma which is also in same industry. Considering Silo already did a share split roll back months ago would be best "value play".
...more
(100)
•••
GajjarDr
X
View Profile
View Bullboard History
Comment by
GajjarDr
on Oct 10, 2022 6:54pm
RE:Quiet Over Here. New Member needs Advice...
I am holder too Silo Wellness. Not to be confused with Silo Pharma which is also in same industry. Considering Silo already did a share split roll back months ago would be best "value play".
...more
(0)
•••
2pacFan
X
View Profile
View Bullboard History
Comment by
2pacFan
on Oct 10, 2022 3:36pm
RE:Quiet Over Here. New Member needs Advice...
Yes, agreed Silo Wellness been watching now since it hit .025. Buying in today after MMED cash out.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >